Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials
- Mateos, M.-V.
- Oriol, A.
- Martínez-López, J.
- Teruel, A.-I.
- Bengoechea, E.
- Palomera, L.
- de Arriba, F.
- Esseltine, D.-L.
- Cakana, A.
- Pei, L.
- van de Velde, H.
- Miguel, J.S.
ISSN: 1432-0584, 0939-5555
Year of publication: 2016
Volume: 95
Issue: 12
Pages: 2033-2041
Type: Article